TIPE2 Associated With Kidney Transplant

NCT01059292 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 93

Last updated 2010-01-29

No results posted yet for this study

Summary

TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. The investigators want to know whether TIPE2 is a risk factor for graft loss and gives rise to the immune dysfunction in renal transplant patients.

Conditions

  • Renal Transplant

Sponsors & Collaborators

  • Xi'an Jiaotong University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01059292 on ClinicalTrials.gov